AZ Groeninge
- Address
- Campus Kennedylaan, President Kennedylaan 4, 8500 Kortrijk, Belgium
Cardiovascular and Neurology Research at AZ Groeninge
Clinical trials at this research site focus on cardiovascular diseases and nervous system diseases, with particular attention to stroke-related care. The studies are exploring ways to improve outcomes for patients after intracerebral haemorrhage and acute ischemic stroke, including those who have recently used direct oral anticoagulants.
- Testing whether a new approach can better prevent major heart and brain-related events after stroke
- Evaluating whether intravenous thrombolysis can improve recovery in selected stroke patients
- Studying treatment strategies for people with complex stroke histories and anticoagulant use
This work aims to refine stroke treatment and support safer, more effective decisions in urgent neurological care.
Blood Cancer Studies in Kortrijk
The site is also involved in neoplasms research, especially for chronic lymphocytic leukemia and small lymphocytic lymphoma. These trials are examining new treatment options for relapsed or hard-to-treat blood cancers, with the goal of improving disease control and extending the time before the cancer progresses.
- Comparing a new therapy with an existing option for better control of CLL and SLL
- Assessing whether emerging treatments can improve progression-free survival
- Focusing on patients whose blood cancers have returned or no longer respond well to prior care
This research reflects an effort to expand options in hematologic oncology and improve outcomes for patients with challenging lymphoid malignancies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1BeOne Medicines AG1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in AZ Groeninge
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Acetylsalicylic Acid and Clopidogrel Monotherapy for Secondary Prevention in Intracerebral Hemorrhage Survivors: A Randomized Controlled Trial | University Of Edinburgh | Phase III | Recruiting | Oct 2025 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2025-10-07 | 2025-10-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.